ClinicalTrials.govpublic full text
Characterization of Adalimumab Concentrations in Pediatric Patients With Inflammatory Rheumatic Disease With and Without Methotrexate
rheumatic diseases, pharmacokinetics, pharmacodynamics, adalimumab, methotrexate, drug-drug interaction, trough ada concentration, peak ada concentration, pediatric inflammatory rheumatic diseases, observational
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 1010958
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.